食品伙伴网讯 据欧盟食品安全局（EFSA）消息，应欧盟委员会的要求，欧盟食品安全局就人工合成的反式白藜芦醇（trans-resveratrol）作为新型食品的安全性发布意见。
申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂，每日用量为150毫克/天。欧盟专家组经过评估认为，代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶，并且可能与CYP2C9代谢后的药物起反应。最后认为，按照规定条件使用反式白藜芦醇是安全的。
部分原文报道如下：
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% （w/w）。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.
原文链接：<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>
本文由食品伙伴网编译，供网友参考，食品伙伴网提供欧盟、美国、英国、俄罗斯、日本、韩国、东南亚、西班牙等国家或地区的进出口合规咨询服务，欢迎垂询：0535-2129301，Email：vip@foodmate.net、news@foodmate.net.
地区：
